




Searching News Database: ESRD
HSMN NewsFeed - 27 Jun 2024
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
HSMN NewsFeed - 30 Oct 2020
Minimally Invasive Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis
Minimally Invasive Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis
HSMN NewsFeed - 9 Jul 2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
HSMN NewsFeed - 28 Aug 2017
NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage(R) System One(TM)
NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage(R) System One(TM)
HSMN NewsFeed - 15 Aug 2017
Pharmalink Strengthens Its Management Team. Appoints New Chief Financial Officer and Head of Communications
Pharmalink Strengthens Its Management Team. Appoints New Chief Financial Officer and Head of Communications
HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Conditional Approval from the European Commission to Treat Multiple Myeloma
HSMN NewsFeed - 7 Jun 2016
Sanifit Appoints Preston S. Klassen MD, MHS as Chief Medical Officer and Announces new US Subsidiary
Sanifit Appoints Preston S. Klassen MD, MHS as Chief Medical Officer and Announces new US Subsidiary
HSMN NewsFeed - 5 Feb 2016
TVA Medical Receives Additional Reimbursement in Germany for the everlinQ(TM) endoAVF System
TVA Medical Receives Additional Reimbursement in Germany for the everlinQ(TM) endoAVF System
HSMN NewsFeed - 29 May 2014
Flow Forward Announces Spinout from Novita, to Focus on Development of Lead Product, the AFE System(TM)
Flow Forward Announces Spinout from Novita, to Focus on Development of Lead Product, the AFE System(TM)
HSMN NewsFeed - 7 Jan 2014
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
HSMN NewsFeed - 20 Dec 2013
Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe
Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe
HSMN NewsFeed - 16 Oct 2013
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
HSMN NewsFeed - 28 Aug 2013
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
HSMN NewsFeed - 10 Jun 2013
TVA Medical Raises $9.5 Million to Advance Minimally Invasive Therapy for End-Stage Renal Disease
TVA Medical Raises $9.5 Million to Advance Minimally Invasive Therapy for End-Stage Renal Disease
HSMN NewsFeed - 30 Apr 2013
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
HSMN NewsFeed - 25 Feb 2013
NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
NxStage Announces CE Mark Approval, First Clinical Use of its Single Needle for Dialysis Patients
HSMN NewsFeed - 21 Feb 2013
NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
NxStage Announces CE Mark Approval for New High Flow Capabilities with System One
HSMN NewsFeed - 15 Jan 2013
Rex Medical Cleaner15 Rotational Thrombectomy System Receives 510(k) Clearance
Rex Medical Cleaner15 Rotational Thrombectomy System Receives 510(k) Clearance
HSMN NewsFeed - 23 Apr 2012
Nephros Appoints John C. Houghton as President and Chief Executive Officer
Nephros Appoints John C. Houghton as President and Chief Executive Officer
HSMN NewsFeed - 22 Feb 2011
Gore Receives CE Mark for GORE(R) PROPATEN(R) Vascular Graft for Hemodialysis Access
Gore Receives CE Mark for GORE(R) PROPATEN(R) Vascular Graft for Hemodialysis Access
HSMN NewsFeed - 12 Aug 2010
First Patient Implanted in Investigational Study for Self Sealing GORE(R) ACUSEAL Vascular Graft
First Patient Implanted in Investigational Study for Self Sealing GORE(R) ACUSEAL Vascular Graft
HSMN NewsFeed - 11 Mar 2010
Rex Medical Cleaner Rotational Thrombectomy System Receives 510(k) Clearance
Rex Medical Cleaner Rotational Thrombectomy System Receives 510(k) Clearance
HSMN NewsFeed - 2 Mar 2010
NxStage(R) and Dirinco Sign Distribution Agreement For System One(TM) in the Netherlands
NxStage(R) and Dirinco Sign Distribution Agreement For System One(TM) in the Netherlands
HSMN NewsFeed - 3 Feb 2010
NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
HSMN NewsFeed - 1 Feb 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel(R)
HSMN NewsFeed - 18 Dec 2009
Xcorporeal Announces Signing Agreement for the Sale of Substantially All of Its Assets
Xcorporeal Announces Signing Agreement for the Sale of Substantially All of Its Assets
HSMN NewsFeed - 17 Jun 2009
NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
HSMN NewsFeed - 23 Apr 2009
Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
HSMN NewsFeed - 8 Oct 2008
Xcorporeal, Inc. Appoints Kelly J. McCrann as Chairman and Chief Executive Officer
Xcorporeal, Inc. Appoints Kelly J. McCrann as Chairman and Chief Executive Officer
HSMN NewsFeed - 17 Sep 2008
Nephros Appoints Ernest A. Elgin III as President and Chief Executive Officer
Nephros Appoints Ernest A. Elgin III as President and Chief Executive Officer
HSMN NewsFeed - 12 Aug 2008
Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
HSMN NewsFeed - 15 May 2008
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
Wyeth's Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
HSMN NewsFeed - 21 Apr 2008
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
HSMN NewsFeed - 7 Apr 2008
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
Keryx Biopharmaceuticals Announces Implementation of Strategic Restructuring Plan
HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
HSMN NewsFeed - 17 Dec 2007
Prestigious Medical Journal Publishes Data on Xcorporeal's Wearable Artificial Kidney
Prestigious Medical Journal Publishes Data on Xcorporeal's Wearable Artificial Kidney
HSMN NewsFeed - 20 Nov 2007
Nephros Receives Approval to Market OLpur(TM) MD Hemodiafilter Series in Canada
Nephros Receives Approval to Market OLpur(TM) MD Hemodiafilter Series in Canada
HSMN NewsFeed - 6 Nov 2007
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
Shire Announces Results of FOSRENOL(R) Study in Pre-Dialysis CKD Stage 3 & 4 Patients
HSMN NewsFeed - 17 Oct 2007
FDA Approves Supplemental New Drug Applications for JANUVIA(TM) (sitagliptin)
FDA Approves Supplemental New Drug Applications for JANUVIA(TM) (sitagliptin)
HSMN NewsFeed - 6 Aug 2007
Baxter Announces Collaboration for Development of Next-Generation Home Hemodialysis Machine
Baxter Announces Collaboration for Development of Next-Generation Home Hemodialysis Machine
HSMN NewsFeed - 19 Mar 2007
Angiotech Initiates U.S. Pivotal Trial for the Vascular Wrap(TM) Paclitaxel-Eluting Mesh
Angiotech Initiates U.S. Pivotal Trial for the Vascular Wrap(TM) Paclitaxel-Eluting Mesh
HSMN NewsFeed - 19 Mar 2007
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for Vascugel(TM)
HSMN NewsFeed - 2 Mar 2007
SEBIVO(R) (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B
SEBIVO(R) (Telbivudine) Approved in China as New Treatment Option for Patients with Chronic Hepatitis B
HSMN NewsFeed - 15 Feb 2007
FDA Accepts Two Supplemental New Drug Applications to Expand the U.S. Labeling for JANUVIA(TM)
FDA Accepts Two Supplemental New Drug Applications to Expand the U.S. Labeling for JANUVIA(TM)
HSMN NewsFeed - 7 Feb 2007
NxStage(R) Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One(TM)
NxStage(R) Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One(TM)
HSMN NewsFeed - 29 Jan 2007
Nephros Receives Conditional Approval from the FDA of Investigational Device Exemption Application
Nephros Receives Conditional Approval from the FDA of Investigational Device Exemption Application
HSMN NewsFeed - 28 Nov 2006
Cardiocom(TM) Announces New GlucoCom(TM) Division and Diabetes Product Sales Team
Cardiocom(TM) Announces New GlucoCom(TM) Division and Diabetes Product Sales Team
HSMN NewsFeed - 27 Nov 2006
NxStage Medical, Inc. Appoints Robert S. Brown as Chief Financial Officer
NxStage Medical, Inc. Appoints Robert S. Brown as Chief Financial Officer
HSMN NewsFeed - 20 Nov 2006
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
HSMN NewsFeed - 16 Oct 2006
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
HSMN NewsFeed - 16 Oct 2006
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
HSMN NewsFeed - 27 Sep 2006
Pervasis Therapeutics' Vascugel(TM) Initiates U.S. Clinical Trials Following Successful FDA IND Review
Pervasis Therapeutics' Vascugel(TM) Initiates U.S. Clinical Trials Following Successful FDA IND Review
Additional items found! 66

Members Archive contains
66 additional stories matching:
ESRD
(Password required)
ESRD
(Password required)